Form 4 for BCRX BIOCRYST PHARMACEUTICALS INC
Accepted 2026-05-15 16:08:01 ET · period of report 2026-05-13 · accession 0000882796-26-000021 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2026-05-15 16:08 | 2026-05-13 | BCRX | Barnes Alane P | CLO | M - OptEx | $5.04 | +62.5K | 463.2K | +16% | +$315.0K |
| DT | 2026-05-15 16:08 | 2026-05-13 | BCRX | Barnes Alane P | CLO | S - Sale+OE | $9.54 | -62.5K | 400.7K | -13% | -$596.2K |
| DT | 2026-05-15 16:08 | 2026-05-13 | BCRX | Barnes Alane P | CLO | M - OptEx | $0.00 | -62.5K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-05-13 | M | A | 62,500 | $5.04 | 463,203 | D | — | — | (F1) This transaction was made pursuant to a plan adopted by the reporting person on August 13, 2025 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. The transaction occurred automatically and does not represent a discretionary transaction by the reporting person. |
| 2 | Common | Common Stock | 2026-05-13 | S | D | 62,500 | $9.54 | 400,703 | D | — | — | (F1) This transaction was made pursuant to a plan adopted by the reporting person on August 13, 2025 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. The transaction occurred automatically and does not represent a discretionary transaction by the reporting person. |
| 3 | Derivative | Emp. Stock Option (Right to Buy) | 2026-05-13 | M | D | 62,500 | $0.00 | 0 | D | $5.04 · 2018-12-20 to 2027-12-20 | 62,500 Common Stock | (F1) This transaction was made pursuant to a plan adopted by the reporting person on August 13, 2025 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. The transaction occurred automatically and does not represent a discretionary transaction by the reporting person. (F2) The option grant became exercisable at the rate of 25% on each of the first, second, third, and fourth anniversaries of the date of grant. |